Merz Pharms Drug Patent Portfolio
Merz Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Merz Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7638552 | Method for increasing the bioavailability of glycopyrrolate | 20 Aug, 2023 | Expired |
| US7816396 | Method for increasing the bioavailability of glycopyrrolate | 20 Aug, 2023 | Expired |
Latest Legal Activities on Merz Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Merz Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 12 Apr, 2022 | US7816396 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Jun, 2021 | US7638552 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 11 Apr, 2018 | US7816396 |
|
Email Notification
Critical
| 07 Dec, 2012 | US7816396 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 07 Dec, 2012 | US7638552 (Litigated) |
|
Email Notification
Critical
| 07 Dec, 2012 | US7638552 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 07 Dec, 2012 | US7816396 |
|
Correspondence Address Change
Critical
| 21 Nov, 2012 | US7638552 (Litigated) |
|
Correspondence Address Change
Critical
| 21 Nov, 2012 | US7816396 |
|
Email Notification
Critical
| 30 Aug, 2011 | US7638552 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 30 Aug, 2011 | US7638552 (Litigated) |
|
Email Notification
Critical
| 29 Aug, 2011 | US7816396 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 29 Aug, 2011 | US7816396 |
|
Correspondence Address Change
Critical
| 26 Aug, 2011 | US7816396 |
|
Correspondence Address Change
Critical
| 26 Aug, 2011 | US7638552 (Litigated) |
Merz Pharms's Family Patents
Merz Pharms Drug List
Given below is the complete list of Merz Pharms's drugs and the patents protecting them.
1. Cuvposa
Cuvposa is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7638552 | Method for increasing the bioavailability of glycopyrrolate |
20 Aug, 2023
(1 year, 1 month ago)
| Expired |
| US7816396 | Method for increasing the bioavailability of glycopyrrolate |
20 Aug, 2023
(1 year, 1 month ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cuvposa's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List